NDVR Inc’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$365K Sell
1,778
-504
-22% -$94.8K 0.3% 31
2025
Q3
$358K Sell
2,282
-2
-0.1% -$309 0.3% 41
2025
Q2
$384K Buy
2,284
+3
+0.1% +$445 0.36% 32
2025
Q1
$314K Sell
2,281
-330
-13% -$42.1K 0.32% 42
2024
Q4
$309K Buy
2,611
+147
+6% +$17.2K 0.3% 47
2024
Q3
$271K Sell
2,464
-43
-2% -$4.5K 0.28% 55
2024
Q2
$246K Sell
2,507
-172
-6% -$17.5K 0.26% 57
2024
Q1
$300K Buy
2,679
+231
+9% +$24.9K 0.29% 40
2023
Q4
$247K Buy
+2,448
New +$243K 0.3% 34

Other funds holding CAH

NDVR Inc's CAH Position: Q4 2025 in Review

NDVR Inc reduced its Cardinal Health (CAH) stake by 22% in Q4 2025, selling an estimated $94.8K and leaving 1,778 shares worth $365K. The position accounts for 0.3% of the portfolio, ranked #31.

NDVR Inc first reported a position in CAH in Q4 2023 and has held it in 9 quarters since. The position peaked at $384K in Q2 2025. 1,405 funds tracked by Wall St. Rank hold CAH as of Q4 2025.

  • NDVR Inc held 1,778 shares of Cardinal Health worth $365K as of Q4 2025.
  • NDVR Inc sold 504 Cardinal Health shares in Q4 2025, an estimated $94.8K.
  • Cardinal Health made up 0.3% of NDVR Inc's portfolio in Q4 2025, its #31 holding.
  • NDVR Inc first reported a position in Cardinal Health in Q4 2023 and has held it in 9 quarters since.
  • NDVR Inc's Cardinal Health position peaked at $384K in Q2 2025.
  • 1,405 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2025.

Based on NDVR Inc's 13F filing for Q4 2025, filed 12 Feb 2026.